OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Multiplexed single-cell pathology reveals the association of CD8 T-cell heterogeneity with prognostic outcomes in renal cell carcinoma
Tetsushi Murakami, Nobuyuki Tanaka, Kimiharu Takamatsu, et al.
Cancer Immunology Immunotherapy (2021) Vol. 70, Iss. 10, pp. 3001-3013
Closed Access | Times Cited: 28
Tetsushi Murakami, Nobuyuki Tanaka, Kimiharu Takamatsu, et al.
Cancer Immunology Immunotherapy (2021) Vol. 70, Iss. 10, pp. 3001-3013
Closed Access | Times Cited: 28
Showing 1-25 of 28 citing articles:
Targeting the PD-1/PD-L1 Signaling Pathway for Cancer Therapy: Focus on Biomarkers
Αreti Strati, Christos Adamopoulos, Ioannis Kotsantis, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 1235-1235
Open Access | Times Cited: 2
Αreti Strati, Christos Adamopoulos, Ioannis Kotsantis, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 1235-1235
Open Access | Times Cited: 2
Updates on Immunotherapy and Immune Landscape in Renal Clear Cell Carcinoma
Myung‐Chul Kim, Jin Zeng, Ryan Kolb, et al.
Cancers (2021) Vol. 13, Iss. 22, pp. 5856-5856
Open Access | Times Cited: 59
Myung‐Chul Kim, Jin Zeng, Ryan Kolb, et al.
Cancers (2021) Vol. 13, Iss. 22, pp. 5856-5856
Open Access | Times Cited: 59
Heterogeneity in tertiary lymphoid structures predicts distinct prognosis and immune microenvironment characterizations of clear cell renal cell carcinoma
Wenhao Xu, Jiahe Lu, Wangrui Liu, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 12, pp. e006667-e006667
Open Access | Times Cited: 32
Wenhao Xu, Jiahe Lu, Wangrui Liu, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 12, pp. e006667-e006667
Open Access | Times Cited: 32
Unveiling the impact of tertiary lymphoid structures on immunotherapeutic responses of clear cell renal cell carcinoma
Wenhao Xu, Jiahe Lu, Xi Tian, et al.
MedComm (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 13
Wenhao Xu, Jiahe Lu, Xi Tian, et al.
MedComm (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 13
Spatial expression of fibroblast activation protein-α in clear cell renal cell carcinomas revealed by multiplex immunoprofiling analysis of the tumor microenvironment
Gorka Larrinaga, Miriam Redrado, Ana Loizaga‐Iriarte, et al.
Cancer Immunology Immunotherapy (2025) Vol. 74, Iss. 2
Open Access | Times Cited: 1
Gorka Larrinaga, Miriam Redrado, Ana Loizaga‐Iriarte, et al.
Cancer Immunology Immunotherapy (2025) Vol. 74, Iss. 2
Open Access | Times Cited: 1
Immune-Associated Gene Signatures Serve as a Promising Biomarker of Immunotherapeutic Prognosis for Renal Clear Cell Carcinoma
Qi Wang, Hanmin Tang, Xuehui Luo, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 24
Qi Wang, Hanmin Tang, Xuehui Luo, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 24
Cell Simulation as Cell Segmentation
Daniel C. Jones, Anna Elz, Azadeh Hadadianpour, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 5
Daniel C. Jones, Anna Elz, Azadeh Hadadianpour, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 5
Hot Spots in Urogenital Basic Cancer Research and Clinics
Claudia Manini, Gorka Larrinaga, J.C. Angulo, et al.
Cancers (2025) Vol. 17, Iss. 7, pp. 1173-1173
Open Access
Claudia Manini, Gorka Larrinaga, J.C. Angulo, et al.
Cancers (2025) Vol. 17, Iss. 7, pp. 1173-1173
Open Access
NKG2A+CD8+T cells infiltration determines immunosuppressive contexture and inferior response to immunotherapy in clear cell renal cell carcinoma
Youqi Qiu, Li Liu, Wenbin Jiang, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 1, pp. e008368-e008368
Open Access | Times Cited: 3
Youqi Qiu, Li Liu, Wenbin Jiang, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 1, pp. e008368-e008368
Open Access | Times Cited: 3
Mechanism underlying the immune checkpoint inhibitor-induced hyper-progressive state of cancer
Peng Ding, Lu Wen, Fan Tong, et al.
Cancer Drug Resistance (2022)
Open Access | Times Cited: 14
Peng Ding, Lu Wen, Fan Tong, et al.
Cancer Drug Resistance (2022)
Open Access | Times Cited: 14
Identification of tumor-specific T cell signature predicting cancer immunotherapy response in bladder cancer by multi-omics analysis and experimental verification
Xiufeng Liu, Chujun Chen, Jiashan Li, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Xiufeng Liu, Chujun Chen, Jiashan Li, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Increased TOX expression concurrent with PD ‐1, Tim‐3, and CD244 expression in T cells from patients with acute myeloid leukemia
Shuxin Huang, Chaofeng Liang, Yujie Zhao, et al.
Cytometry Part B Clinical Cytometry (2021) Vol. 102, Iss. 2, pp. 143-152
Open Access | Times Cited: 15
Shuxin Huang, Chaofeng Liang, Yujie Zhao, et al.
Cytometry Part B Clinical Cytometry (2021) Vol. 102, Iss. 2, pp. 143-152
Open Access | Times Cited: 15
A Web-Based Prediction Model for Cancer-Specific Survival of Elderly Patients With Clear Cell Renal Cell Carcinoma: A Population-Based Study
Chenghao Zhanghuang, Jinkui Wang, Zhaoxia Zhang, et al.
Frontiers in Public Health (2022) Vol. 9
Open Access | Times Cited: 9
Chenghao Zhanghuang, Jinkui Wang, Zhaoxia Zhang, et al.
Frontiers in Public Health (2022) Vol. 9
Open Access | Times Cited: 9
CEACAM1 Is a Prognostic Biomarker and Correlated with Immune Cell Infiltration in Clear Cell Renal Cell Carcinoma
Lu Yang, Yun Liu, Boke Zhang, et al.
Disease Markers (2023) Vol. 2023, pp. 1-12
Open Access | Times Cited: 4
Lu Yang, Yun Liu, Boke Zhang, et al.
Disease Markers (2023) Vol. 2023, pp. 1-12
Open Access | Times Cited: 4
CXCR3 Expression Is Associated with Advanced Tumor Stage and Grade Influencing Survival after Surgery of Localised Renal Cell Carcinoma
Andrea Katharina Lindner, Agnieszka Martowicz, Gerold Untergasser, et al.
Cancers (2023) Vol. 15, Iss. 4, pp. 1001-1001
Open Access | Times Cited: 4
Andrea Katharina Lindner, Agnieszka Martowicz, Gerold Untergasser, et al.
Cancers (2023) Vol. 15, Iss. 4, pp. 1001-1001
Open Access | Times Cited: 4
Identification and validation of fatty acid metabolism-related lncRNA signatures as a novel prognostic model for clear cell renal cell carcinoma
Cheng Shen, Zhan Chen, Jie Jiang, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 4
Cheng Shen, Zhan Chen, Jie Jiang, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 4
Impact of LAG-3/FGL1 pathway on immune evasive contexture and clinical outcomes in advanced urothelial carcinoma
Takashi Yoshida, Takahiro Nakamoto, Naho Atsumi, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 7, pp. e009358-e009358
Open Access | Times Cited: 1
Takashi Yoshida, Takahiro Nakamoto, Naho Atsumi, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 7, pp. e009358-e009358
Open Access | Times Cited: 1
Fc receptor‐like A promotes malignant behavior in renal cell carcinoma and correlates with tumor immune infiltration
Junpeng Liu, Yi‐fan Jiang, Jinwen Liu, et al.
Cancer Medicine (2024) Vol. 13, Iss. 15
Open Access | Times Cited: 1
Junpeng Liu, Yi‐fan Jiang, Jinwen Liu, et al.
Cancer Medicine (2024) Vol. 13, Iss. 15
Open Access | Times Cited: 1
Integrative Analysis Identifies TCIRG1 as a Potential Prognostic and Immunotherapy-Relevant Biomarker Associated with Malignant Cell Migration in Clear Cell Renal Cell Carcinoma
Chao Xu, Bolin Jia, Zhan Yang, et al.
Cancers (2022) Vol. 14, Iss. 19, pp. 4583-4583
Open Access | Times Cited: 7
Chao Xu, Bolin Jia, Zhan Yang, et al.
Cancers (2022) Vol. 14, Iss. 19, pp. 4583-4583
Open Access | Times Cited: 7
Long-Term Survival of Patients with Stage T1N0M1 Renal Cell Carcinoma
Viktoria Schütz, Huancai Lin, Adam Kaczorowski, et al.
Cancers (2023) Vol. 15, Iss. 24, pp. 5715-5715
Open Access | Times Cited: 2
Viktoria Schütz, Huancai Lin, Adam Kaczorowski, et al.
Cancers (2023) Vol. 15, Iss. 24, pp. 5715-5715
Open Access | Times Cited: 2
Comprehensive analysis of 7-methylguanosine and immune microenvironment characteristics in clear cell renal cell carcinomas
Xiao Yu, Junfeng Yang, Maolin Yang, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 4
Xiao Yu, Junfeng Yang, Maolin Yang, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 4
Seven Fatty Acid Metabolism-Related Genes as Potential Biomarkers for Predicting the Prognosis and Immunotherapy Responses in Patients with Esophageal Cancer
Ya Guo, Shupei Pan, Yue Ke, et al.
Vaccines (2022) Vol. 10, Iss. 10, pp. 1721-1721
Open Access | Times Cited: 3
Ya Guo, Shupei Pan, Yue Ke, et al.
Vaccines (2022) Vol. 10, Iss. 10, pp. 1721-1721
Open Access | Times Cited: 3
The potential value of dual-energy CT radiomics in evaluating CD8+, CD163+ and αSMA+ cells in the tumor microenvironment of clear cell renal cell carcinoma
Ruobing Li, Bing Xue, Xinyou Su, et al.
Clinical & Translational Oncology (2024)
Closed Access
Ruobing Li, Bing Xue, Xinyou Su, et al.
Clinical & Translational Oncology (2024)
Closed Access
Multiplexed spatial imaging at the single-cell level reveals mutually exclusive expression of B7 family proteins
Kazunori Shojo, Nobuyuki Tanaka, Tetsushi Murakami, et al.
Laboratory Investigation (2024) Vol. 104, Iss. 10, pp. 102131-102131
Closed Access
Kazunori Shojo, Nobuyuki Tanaka, Tetsushi Murakami, et al.
Laboratory Investigation (2024) Vol. 104, Iss. 10, pp. 102131-102131
Closed Access
CD8 + Tumor-Infiltrating Lymphocytes in Head and Neck Cancer: A Review
Kevin J. Contrera, Matthew E. Spector, Liron Pantanowitz, et al.
JCO Precision Oncology (2024), Iss. 8
Closed Access
Kevin J. Contrera, Matthew E. Spector, Liron Pantanowitz, et al.
JCO Precision Oncology (2024), Iss. 8
Closed Access
